Company Filing History:
2 out of 6 
1 out of 2 
1 out of 1 Years Active: 1998-2009
Title: The Innovations of Robert Ruffolo, Jr.
Introduction
Robert Ruffolo, Jr. is a notable inventor based in Spring City, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of congestive heart failure. With a total of 4 patents to his name, Ruffolo's work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents is the "Use of carbazole compounds for the treatment of congestive heart failure." This patent discloses a method of treatment using carvedilol, which decreases the risk of mortality caused by congestive heart failure in patients. The method involves titrating patients with low amounts of carvedilol, starting with an initial dosage of only 10 to 30% of the daily maintenance dose. Another significant patent is the "Method of treatment for decreasing mortality resulting from congestive heart failure," which utilizes a compound of Formula I.
Career Highlights
Throughout his career, Ruffolo has worked with prominent companies in the pharmaceutical industry. Notable among these are Sb Pharmco Puerto Rico Inc. and Boehringer Mannheim Pharmaceuticals Corporation, which is now part of SmithKline Beecham. His work in these organizations has contributed to advancements in medical treatments.
Collaborations
Ruffolo has collaborated with several professionals in his field, including Klaus Strein and Neil Howard Shusterman. These collaborations have likely enriched his research and development efforts.
Conclusion
Robert Ruffolo, Jr. is a distinguished inventor whose work in the pharmaceutical industry has led to important advancements in the treatment of congestive heart failure. His patents reflect a commitment to improving patient outcomes and enhancing medical practices.